New stock news | It is rumored that Feisu Innovation will launch its IPO this week with a goal of raising HK$1.56 billion.
Shenzhen Feisuchuangxin Technology Co., Ltd. (referred to as "Feisuchuangxin") held a listing hearing on Monday (March 2nd) through the Hong Kong Stock Exchange, and market news said that it has started a pre-roadshow.
Shenzhen Feisuchuangxin Technology Co., Ltd. (referred to as Feisuchuangxin) went through the listing hearing on the Hong Kong Stock Exchange last Monday (March 2), with market news suggesting that the company has started the pre-roadshow. It is reported that Feisuchuangxin will launch the IPO as soon as this week, aiming to raise approximately 200 million US dollars (about 1.56 billion Hong Kong dollars). CICC, China Securities Co., Ltd. and CMSC will act as joint sponsors.
According to the prospectus, based on data from Frost & Sullivan and projected revenue in 2024, Feisuchuangxin is the world's second-largest online DTC network solutions provider, with a market share of 6.9%. The company's network solutions enable global enterprises to achieve efficient digital transformation.
Through its online sales platform FS.com, Feisuchuangxin provides scalable, cost-effective and all-in-one network solutions. The company's solutions range from high-performance network devices, scalable network device operating systems to cloud network management platforms. The solutions support scenarios such as high-performance computing, data centers, enterprise networks and telecommunications. By focusing on platform-centric, online-enabled methods, Feisuchuangxin meets the global demand for enterprise-level high-performance network solutions and foundational network solutions.
In terms of finances, for the fiscal years ending on September 30 of 2022, 2023, 2024, and the nine months ended on September 30, 2025, Feisuchuangxin achieved revenues of approximately 1.988 billion yuan, 2.213 billion yuan, 2.612 billion yuan, 1.954 billion yuan, and 2.175 billion yuan respectively. During the same periods, the company's gross profits were approximately 903 million yuan, 1.092 billion yuan, 1.306 billion yuan, 996 million yuan, and 1.143 billion yuan respectively.
The funds raised this time will be used for enhancing the digitization of its technology platform over the next 5 years, improving delivery capabilities in key overseas markets, digitizing the network solutions and service business platform, as well as for operational and general corporate purposes.
Related Articles

GENSCRIPT BIO (01548) releases annual financial results, with a net loss attributable to shareholders of 533 million USD, a year-on-year shift from profit to loss.

SINOPEC SEG (02386) releases annual results, with shareholders' profit of 1.798 billion yuan, a year-on-year decrease of 27.1%.

CITIC SEC: The impact of rising PET prices is controllable, and beverage companies are expected to reduce hedging costs.
GENSCRIPT BIO (01548) releases annual financial results, with a net loss attributable to shareholders of 533 million USD, a year-on-year shift from profit to loss.

SINOPEC SEG (02386) releases annual results, with shareholders' profit of 1.798 billion yuan, a year-on-year decrease of 27.1%.

CITIC SEC: The impact of rising PET prices is controllable, and beverage companies are expected to reduce hedging costs.






